Symlin drug improves glucose control in diabetes patients: Amylin
Saturday, September 09, 2006 12:00 IST San Diego
Amylin Pharmaceuticals, Inc. announced positive results from a 16-week study evaluating the safety and efficacy of adding Symlin (pramlintide acetate) to an established regimen of basal insulin glargine
